Literature DB >> 27739263

Effect of Carica papaya Leaf Extract Capsule on Platelet Count in Patients of Dengue Fever with Thrombocytopenia.

Ajeet Kumar Gadhwal1, B S Ankit1, Chitresh Chahar1, Pankaj Tantia2, P Sirohi3, R P Agrawal4.   

Abstract

OBJECTIVE: Thrombocytopenia in dengue fever is a common and serious complication. However, no specific treatment is available for dengue fever induced thrombocytopenia. In few countries (Pakistan, Malaysia, Sri Lanka and other Asian countries) the leaf extract of Carica papaya has been effectively used for thrombocytopenia. So, the study is planned to access effect of Carica papaya leaf extract on platelet count in dengue fever patients.
METHODS: All participants were randomised into two groups, study group and control group; the study group was given papaya leaf extract capsule of 500 mg once daily and routine supportive treatment for consecutive five days. The controls were given only routine supportive treatment. Daily complete blood counts, platelet counts and haematocrit level, liver function test, renal function test of both groups were observed.
RESULTS: On the first day platelet count of study group and control group was (59.82±18.63, 61.06±20.03 thousands, p value 0.36). On the 2nd day platelet count of both study and control groups was not significantly different (61.67±19.46 and 59.93±19.52 thousands, p value 0.20) but on 3rd day platelet count of study group was significantly higher than control group (82.96±16.72, 66.45±17.36 thousands, p value < 0.01). On 4th and 5th day platelet count of study group (122.43±19.36 and 112.47±17.49 thousands respectively) was also significantly higher than the control group (88.75±21.65 and 102.59±19.35 thousands) (p value < 0.01). On 7th day platelet count of study group and control group were not significantly different (124.47±12.35 and 122.46±19.76 thousands respectively, p value 0.08). Average hospitalization period of study group v/s control group was 3.65±0.97 v/s 5.42±0.98 days (p value < 0.01). Average platelet transfusion requirement in study group was significantly less than control group (0.685 units per patient v/s 1.19 units per patient) (p value <0.01).
CONCLUSIONS: It is concluded that Carica papaya leaf extract increases the platelet count in dengue fever without any side effect and prevents the complication of thrombocytopenia. So, it can be used in dengue fever with thrombocytopenia patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27739263

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  10 in total

Review 1.  Carica papaya L. Leaves: Deciphering Its Antioxidant Bioactives, Biological Activities, Innovative Products, and Safety Aspects.

Authors:  Anshu Sharma; Ruchi Sharma; Munisha Sharma; Manoj Kumar; Mrunal Deepak Barbhai; José M Lorenzo; Somesh Sharma; Mahesh Kumar Samota; Maria Atanassova; Gianluca Caruso; Mo Naushad; Deepak Chandran; Pramod Prakash; Muzaffar Hasan; Nadeem Rais; Abhijit Dey; Dipendra Kumar Mahato; Sangram Dhumal; Surinder Singh; Marisennayya Senapathy; Sureshkumar Rajalingam; Marthandan Visvanathan; Lejaniya Abdul Kalam Saleena; Mohamed Mekhemar
Journal:  Oxid Med Cell Longev       Date:  2022-06-09       Impact factor: 7.310

2.  The effect of freeze-dried Carica papaya leaf juice treatment on NS1 and viremia levels in dengue fever mice model.

Authors:  Mohd Ridzuan Mohd Abd Razak; Norazlan Mohmad Misnan; Nur Hana Md Jelas; Nor Azrina Norahmad; Amirrudin Muhammad; Tiffiny Chau Dee Ho; Bazilah Jusoh; Umi Rubiah Sastu; Murizal Zainol; Mohd Isa Wasiman; Hussin Muhammad; Ravindran Thayan; Ami Fazlin Syed Mohamed
Journal:  BMC Complement Altern Med       Date:  2018-12-05       Impact factor: 3.659

3.  An open-label, randomized prospective study to evaluate the efficacy and safety of Carica papaya leaf extract for thrombocytopenia associated with dengue fever in pediatric subjects.

Authors:  B K Srikanth; Lakshminarayana Reddy; Sunita Biradar; Manjula Shamanna; Deepak D Mariguddi; M Krishnakumar
Journal:  Pediatric Health Med Ther       Date:  2019-01-17

4.  Carica papaya extract in dengue: a systematic review and meta-analysis.

Authors:  Senaka Rajapakse; Nipun Lakshitha de Silva; Praveen Weeratunga; Chaturaka Rodrigo; Chathurani Sigera; Sumadhya Deepika Fernando
Journal:  BMC Complement Altern Med       Date:  2019-10-11       Impact factor: 3.659

Review 5.  Potential Medicinal Plants for the Treatment of Dengue Fever and Severe Acute Respiratory Syndrome-Coronavirus.

Authors:  Mohammed S M Saleh; Yusof Kamisah
Journal:  Biomolecules       Date:  2020-12-30

6.  A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient.

Authors:  Abigail Koehler; Rohan Rao; Yehudit Rothman; Yair M Gozal; Timothy Struve; Lise Alschuler; Soma Sengupta
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

7.  The attenuation effect of low piperine Piper nigrum extract on doxorubicin-induced toxicity of blood chemical and immunological properties in mammary tumour rats.

Authors:  Jirakrit Saetang; Aman Tedasen; Surasak Sangkhathat; Natnaree Sangkaew; Sirinapa Dokduang; Napat Prompat; Siriporn Taraporn; Potchanapond Graidist
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

8.  Effect of doxycycline and doxycycline with carica papaya on thrombocytopenia and leucopenia in acute dengue fever patients.

Authors:  Vivek Pambhar; Navgeet Mathur; Amit Mehta; Medha Mathur; Dal Chand Kumawat; Ravi Mangalia; Anjana Verma; Ashish Patyal
Journal:  J Family Med Prim Care       Date:  2022-06-30

9.  Dengue Outbreaks in Khyber Pakhtunkhwa (KPK), Pakistan in 2017: An Integrated Disease Surveillance and Response System (IDSRS)-Based Report.

Authors:  Sher Ali; Muhammad Salman; Misbahud Din; Kachkol Khan; Munib Ahmad; Faisal Hayat Khan; Muhammad Arif
Journal:  Pol J Microbiol       Date:  2019

Review 10.  Carica papaya L. Leaf: A Systematic Scoping Review on Biological Safety and Herb-Drug Interactions.

Authors:  X Y Lim; J S W Chan; N Japri; J C Lee; T Y C Tan
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.